EPHA2 and prostate carcinoma: EphA2 expression levels in several prostate cancer cell lines and patient-derived samples have been analyzed and evidenced that metastatic prostate cancer cells present EphA2 protein expression levels 10–100 fold higher than those in non-invasive prostatic epithelial cells [120].